Every 8-K that GREATER CANNABIS CO (GCAN) has filed with the SEC in the last 24 months is listed below, newest first, and each one links through to the document itself with the summary and the scores our analysis gives it.
A 8-K covers material events a company has to report between its quarterly reports, so if you follow GCAN and want that one kind of document rather than the whole filing history, this is the page to keep. The company's other filings, of every form, are on the full GCAN filings page.
The Greater Cannabis Company, Inc. approved significant governance and capital-structure changes on July 29, 2026. The board expanded to add Carlos Septién, Michelle Cervantes Vivanco and Ernesto Gómez Berjón as directors, with Septién becoming Chief Operating Officer, Cervantes Vivanco Chief Financial Officer and Gómez Berjón Chief Growth Officer, while Porfirio Sanchez Talavera remains Chief Executive Officer and Chairman. These director appointments become effective after a ten-day Schedule 14F-1 information period.
The board authorized a corporate name change to Trafalgar International, Inc. and a one-for-five (1-for-5) reverse stock split of issued and outstanding Common Stock, with fractional shares rounded up, leaving authorized Common and Preferred Stock unchanged. Articles of Amendment and related regulatory submissions, including FINRA corporate action notifications, will determine the effective dates. The board also adopted Amended and Restated Bylaws to align with the company’s current governance structure.
The Greater Cannabis Company reported a change in control and leadership following privately negotiated transactions completed on June 29, 2026. Trafalgar Asset Management, LLC, owned and controlled by Porfirio Sánchez Talavera, purchased 7,628,665 shares of Series A Preferred Stock and 1,000 shares of Series B Preferred Stock, representing all outstanding shares of both classes. Based on 994,379 common shares outstanding, the preferred holdings give Trafalgar approximately 96.62% of the company’s total voting power, establishing clear voting control.
Concurrently, the company entered into Debt Cancellation and Release Agreements with certain creditors, under which specified indebtedness was compromised, settled, canceled, and extinguished. In connection with the change in control, Sánchez Talavera was appointed Chief Executive Officer, Chairman, and sole director (after a Rule 14f‑1 transition period), while long‑time executive Aitan Zacharin resigned from all officer roles and will depart the board following the required notice period.
The Greater Cannabis Company (GCAN) created a new Series B Convertible Preferred Stock and issued it to CEO Aitan Zacharin in exchange for waiving $20,000 of accrued compensation. The Series B carries super‑voting rights equal to 51.0% of the Company’s total voting power, giving him control of corporate decisions.
Each Series B share is convertible at the holder’s option into common stock at a rate of 100,000 common shares per preferred share, subject to customary adjustments for stock splits or combinations. The super‑voting rights terminate if any Series B is converted in part or transferred to a third party, after which the shares vote on an as‑converted basis with other classes. The Series B has no dividend rights and a liquidation preference of $0.001 per share.
The Greater Cannabis Company (GCAN) amended its report to update timing for a reverse stock split. A 1-for-1,500 reverse split is effective as of the close of business on October 16, 2025, after a one-day delay due to a FINRA Daily List omission.
The stock will trade on a post-split basis starting October 17, 2025, under ticker GCAND for twenty trading days, with new CUSIP 391657202. Issued and outstanding common shares will be reduced from 1,349,888,436 to approximately 900,256. No fractional shares will be issued; holders otherwise entitled to a fraction will receive one whole share. Authorized shares and the $0.001 par value are unchanged. The split also applies to shares issuable upon conversion of outstanding convertible debt, warrants, and options.
The Greater Cannabis Company (GCAN) is implementing a 1-for-1,500 reverse stock split of its common stock, effective as of the close of business on October 15, 2025. The stock will begin trading on a post-split basis on October 16, 2025 under the temporary ticker GCAND for twenty trading days, with a new CUSIP 391657202.
The reverse split reduces issued and outstanding common shares from 1,349,888,436 to approximately 900,256. No fractional shares will be issued; holders entitled to a fraction will receive one whole share. The action also applies to shares issuable upon conversion of outstanding convertible debt, warrants, and options. Authorized shares and par value ($0.001) remain unchanged, and the company notes it will have additional shares available for potential future issuance, without specific plans beyond honoring existing convertible and equity awards.